ETERNA THERAPEUTICS INC (ERNA)
US1140822099 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 4.26M | 7.58M | 11.45M | 16.99M | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 780.00K | |||
| Receivables | 187.00K | 425.00K | 950.00K | 680.00K | 120.00K | |||
| Other Current Assets | 279.00K | 1.60M | 1.28M | 1.10M | 840.00K | |||
| Total Current Assets | 4.73M | 9.60M | 13.68M | 18.77M | 1.72M | |||
| Non-Current Assets | ||||||||
| PPE Net | 824.00K | 33.27M | 1.33M | 4.24M | 540.00K | |||
| Investments And Advances | N/A | N/A | N/A | 490.00K | N/A | |||
| Goodwill | 2.04M | 2.04M | 2.04M | 2.04M | 0.00 | |||
| Intangibles | N/A | N/A | 0.00 | 5.99M | 1.36M | |||
| Other Non-Current Assets | 120.00K | 4.21M | 5.23M | N/A | 120.00K | |||
| Total Non-Current Assets | 2.99M | 39.53M | 8.60M | 12.76M | 2.03M | |||
| TOTAL ASSETS | 7.72M | 49.13M | 22.28M | 31.53M | 3.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 776.00K | 1.21M | 1.75M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 559.00K | N/A | N/A | 0.00 | 1.52M | |||
| Accrued Expenses | 1.37M | 4.11M | 3.92M | 1.68M | 340.00K | |||
| Accounts Payable | 2.19M | 1.07M | 1.62M | 1.76M | 270.00K | |||
| Other Current Liabilities | 5.06M | 192.00K | 360.00K | 250.00K | 220.00K | |||
| Total Current Liabilities | 9.95M | 6.57M | 7.65M | 3.68M | 2.36M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 32.04M | 6.77M | 1.21M | 0.00 | 530.00K | |||
| Other Non-Current Liabilities | 11.12M | 33.55M | 1.31M | 2.35M | 0.00 | |||
| Total Non-Current Liabilities | 43.16M | 40.33M | 2.52M | 2.34M | 530.00K | |||
| TOTAL LIABILITIES | 53.11M | 46.90M | 10.17M | 6.02M | 2.89M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -225.77M | -186.98M | -165.30M | -140.70M | -135.89M | |||
| Additional Paid In Capital | 180.35M | 189.19M | 177.38M | 165.94M | 136.93M | |||
| Common Shares | 28.00K | 28.00K | 30.00K | 260.00K | 20.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | -460.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 250.00K | |||
| Shares Outstanding | 5.41M | 5.41M | 5.13M | 2.60M | 70.00K | |||
| Tangible Book Value per Share | -8.77 | 0.03 | 1.96 | 6.72 | -7.29 | |||
| Total Shareholders' Equity | -45.39M | 2.23M | 12.11M | 25.50M | 850.00K | |||
| TOTAL LIABILITIES AND EQUITY | 7.72M | 49.13M | 22.28M | 31.53M | 3.75M | |||
| Statistics | ||||||||
| Debt/Equity | -0.72 | 3.57 | 0.24 | N/A | 0.62 | |||
| Current Ratio | 0.48 | 1.46 | 1.79 | 5.10 | 0.73 | |||
| Return On Assets (ROA) | -582.39% | -44.13% | -110.41% | -388.71% | -118.13% | |||
| Return On Equity (ROE) | N/A | -971.07% | -203.14% | -480.63% | -521.18% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21